+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Potential of cationic porphyrins for photodynamic treatment of cutaneous Leishmaniasis



Potential of cationic porphyrins for photodynamic treatment of cutaneous Leishmaniasis



Photodiagnosis and Photodynamic Therapy 3(3): 162-167



Four tetracationic porphyrins have been investigated for their ability to photo-inactivate Leishmania major promastigotes. Parallel photocytotoxicity assays against keratinocytes and macrophages show significant differences in activity between the microorganism and mammalian cells. Results suggest that it may be possible to photodynamically inactivate macrophages infected with Leishmania and the promastigote form of the microorganism, while minimising damage to surrounding tissue.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 055082073

Download citation: RISBibTeXText

PMID: 25049150

DOI: 10.1016/j.pdpdt.2006.04.004


Related references

Synthesis of calcium phosphate nanostructures by combustion in solution as a potential encapsulant system of drugs with photodynamic properties for the treatment of cutaneous leishmaniasis. Photodiagnosis and Photodynamic Therapy 21: 138-146, 2018

Synthesis of calcium phosphate nanostructures by combustion in solution as a potential encapsulant system of drugs with photodynamic properties for the treatment of cutaneous leishmaniasis. Photodiagnosis and Photodynamic Therapy 21: 138-146, 2018

Photodynamic treatment of cutaneous leishmaniasis. Journal der Deutschen Dermatologischen Gesellschaft 5(2): 128-130, 2007

Photodynamic Therapy in the Treatment of Cutaneous Leishmaniasis. Actas Dermo-Sifiliograficas 110(3): 249-251, 2019

Treatment of cutaneous leishmaniasis with photodynamic therapy. Archives of Dermatology 139(4): 432-434, 2003

Treatment of cutaneous leishmaniasis by photodynamic therapy. Journal of the American Academy of Dermatology 50(6): E12; Author Reply E13, 2004

Photodynamic therapy as a new treatment of cutaneous leishmaniasis. Eastern Mediterranean Health Journal 12(6): 902-908, 2006

Treatment of cutaneous leishmaniasis by photodynamic therapy. Journal of the American Academy of Dermatology 48(6): 893-896, 2003

Successful treatment of cutaneous leishmaniasis by photodynamic therapy and cryotherapy. European Journal of Dermatology 19(2): 172-173, 2009

The potential of daylight-activated photodynamic therapy for treating localized forms of cutaneous leishmaniasis in resource-limited settings. British Journal of Dermatology 172(5): 1192-1193, 2015

Successful treatment of cutaneous leishmaniasis with intralesional aminolevulinic acid photodynamic therapy. Photodermatology Photoimmunology and Photomedicine 27(5): 254-256, 2011

Relocalization of cationic porphyrins during photodynamic therapy. Photochemical & Photobiological Sciences 1(11): 837-840, 2002

Relocalization of cationic porphyrins during photodynamic therapy. Photochemical and Photobiological Sciences 1(11): 837-840, 2002

Cutaneous leishmaniasis: the efficacy of nonantimony treatment in the austere environment. Using cryotherapy, thermotherapy, and photodynamic therapy as an alternative method of treatment. Journal of Special Operations Medicine 13(4): 40-45, 2013

Effective treatment of cutaneous leishmaniasis caused by Leishmania tropica with topical photodynamic therapy. Journal der Deutschen Dermatologischen Gesellschaft 14(8): 836-838, 2016